☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
P-I trial
Celltrion Plans to Initiate P-I Trial for its CT-P41 (biosimilar- denosumab) in September 2020
August 14, 2020
Xspray Pharma Reports Positive P-I Trial Results of HyNap-Dasa for the Treatment of Chronic Myeloid Leukemia (CML)
September 10, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.